PEDIATRICS Vol. 55 No. 1 January 1975, pp. 142-143
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yaffe, S. J.
Right arrow Articles by Chudzik, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yaffe, S. J.
Right arrow Articles by Chudzik, G.

Requiem for Tetracyclines

Committee on Drugs

Sumner J. Yaffe M.D., C. Warren Bierman M.D., Howard M. Cann M.D., Sanford N. Cohen M.D., John Freeman M.D., Sydney Segal M.D., Lester F. Soyka M.D., Charles F. Weiss M.D., and Gregory Chudzik Pharm.D.

There are few if any reasons for using tetracycline drugs in children less than 8 years old. This class of antibiotics is capable of producing many adverse effects, two of which are specific for younger children and one of which is irreversible. Accordingly, it is difficult to justify the continued availability of drop or syrup formulations of tetracyclines. As long as they continue to be marketed, physicians who care for children should make every effort to discourage their use and curtail prescribing tetracycline for pediatric patients.




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
A. K. Shetty
Tetracyclines in Pediatrics Revisited
Clinical Pediatrics, May 1, 2002; 41(4): 203 - 209.
[PDF]

Home page
 J Hum LactHome page
K. G. Chin, C. E. McPherson III, M. Hoffman, A. Kuchta, and C. Mactal-Haaf
Use of Anti-Infective Agents During Lactation: Part 2--Aminoglycosides, Macrolides, Quinolones, Sulfonamides, Trimethoprim, Tetracyclines, Chloramphenicol, Clindamycin, and Metronidazole
J Hum Lact, February 1, 2001; 17(1): 54 - 65.
[Abstract] [PDF]